285 related articles for article (PubMed ID: 26415756)
1. A novel delivery platform based on Bacteriophage MS2 virus-like particles.
Fu Y; Li J
Virus Res; 2016 Jan; 211():9-16. PubMed ID: 26415756
[TBL] [Abstract][Full Text] [Related]
2. Dual Surface Modification of Genome-Free MS2 Capsids for Delivery Applications.
Aanei IL; Francis MB
Methods Mol Biol; 2018; 1776():629-642. PubMed ID: 29869270
[TBL] [Abstract][Full Text] [Related]
3. Production in Saccharomycescerevisiae of MS2 virus-like particles packaging functional heterologous mRNAs.
Legendre D; Fastrez J
J Biotechnol; 2005 May; 117(2):183-94. PubMed ID: 15823407
[TBL] [Abstract][Full Text] [Related]
4. Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles.
Pan Y; Zhang Y; Jia T; Zhang K; Li J; Wang L
FEBS J; 2012 Apr; 279(7):1198-208. PubMed ID: 22309233
[TBL] [Abstract][Full Text] [Related]
5. MS2 viruslike particles: a robust, semisynthetic targeted drug delivery platform.
Galaway FA; Stockley PG
Mol Pharm; 2013 Jan; 10(1):59-68. PubMed ID: 23110441
[TBL] [Abstract][Full Text] [Related]
6. A Selection for Assembly Reveals That a Single Amino Acid Mutant of the Bacteriophage MS2 Coat Protein Forms a Smaller Virus-like Particle.
Asensio MA; Morella NM; Jakobson CM; Hartman EC; Glasgow JE; Sankaran B; Zwart PH; Tullman-Ercek D
Nano Lett; 2016 Sep; 16(9):5944-50. PubMed ID: 27549001
[TBL] [Abstract][Full Text] [Related]
7. A new RNA vaccine platform based on MS2 virus-like particles produced in Saccharomyces cerevisiae.
Sun S; Li W; Sun Y; Pan Y; Li J
Biochem Biophys Res Commun; 2011 Apr; 407(1):124-8. PubMed ID: 21362402
[TBL] [Abstract][Full Text] [Related]
8. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.
Ashley CE; Carnes EC; Phillips GK; Durfee PN; Buley MD; Lino CA; Padilla DP; Phillips B; Carter MB; Willman CL; Brinker CJ; Caldeira Jdo C; Chackerian B; Wharton W; Peabody DS
ACS Nano; 2011 Jul; 5(7):5729-45. PubMed ID: 21615170
[TBL] [Abstract][Full Text] [Related]
9. Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.
Li J; Sun Y; Jia T; Zhang R; Zhang K; Wang L
Int J Cancer; 2014 Apr; 134(7):1683-94. PubMed ID: 24105486
[TBL] [Abstract][Full Text] [Related]
10. Measurements of the self-assembly kinetics of individual viral capsids around their RNA genome.
Garmann RF; Goldfain AM; Manoharan VN
Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22485-22490. PubMed ID: 31570619
[TBL] [Abstract][Full Text] [Related]
11. Optimizing the synthesis and purification of MS2 virus like particles.
Hashemi K; Ghahramani Seno MM; Ahmadian MR; Malaekeh-Nikouei B; Bassami MR; Dehghani H; Afkhami-Goli A
Sci Rep; 2021 Oct; 11(1):19851. PubMed ID: 34615923
[TBL] [Abstract][Full Text] [Related]
12. The structure of bacteriophage phiCb5 reveals a role of the RNA genome and metal ions in particle stability and assembly.
Plevka P; Kazaks A; Voronkova T; Kotelovica S; Dishlers A; Liljas L; Tars K
J Mol Biol; 2009 Aug; 391(3):635-47. PubMed ID: 19559027
[TBL] [Abstract][Full Text] [Related]
13. Effect of coat-protein concentration on the self-assembly of bacteriophage MS2 capsids around RNA.
Williams LA; Neophytou A; Garmann RF; Chakrabarti D; Manoharan VN
Nanoscale; 2024 Feb; 16(6):3121-3132. PubMed ID: 38258446
[TBL] [Abstract][Full Text] [Related]
14. Virus-like particles derived from bacteriophage MS2 as antigen scaffolds and RNA protective shells.
Naskalska A; Heddle JG
Nanomedicine (Lond); 2024; 19(12):1103-1115. PubMed ID: 38629576
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2.
Peabody DS; Manifold-Wheeler B; Medford A; Jordan SK; do Carmo Caldeira J; Chackerian B
J Mol Biol; 2008 Jun; 380(1):252-63. PubMed ID: 18508079
[TBL] [Abstract][Full Text] [Related]
16. Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma.
Wang G; Jia T; Xu X; Chang L; Zhang R; Fu Y; Li Y; Yang X; Zhang K; Lin G; Han Y; Li J
Oncotarget; 2016 Sep; 7(37):59402-59416. PubMed ID: 27449085
[TBL] [Abstract][Full Text] [Related]
17. Analysis of phage MS2 coat protein mutants expressed from a reconstituted phagemid reveals that proline 78 is essential for viral infectivity.
Hill HR; Stonehouse NJ; Fonseca SA; Stockley PG
J Mol Biol; 1997 Feb; 266(1):1-7. PubMed ID: 9054964
[TBL] [Abstract][Full Text] [Related]
18. The MS2 coat protein shell is likely assembled under tension: a novel role for the MS2 bacteriophage A protein as revealed by small-angle neutron scattering.
Kuzmanovic DA; Elashvili I; Wick C; O'Connell C; Krueger S
J Mol Biol; 2006 Feb; 355(5):1095-111. PubMed ID: 16359706
[TBL] [Abstract][Full Text] [Related]
19. RNA bacteriophage capsid-mediated drug delivery and epitope presentation.
Brown WL; Mastico RA; Wu M; Heal KG; Adams CJ; Murray JB; Simpson JC; Lord JM; Taylor-Robinson AW; Stockley PG
Intervirology; 2002; 45(4-6):371-80. PubMed ID: 12602361
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer.
Zhai L; Yadav R; Kunda NK; Anderson D; Bruckner E; Miller EK; Basu R; Muttil P; Tumban E
Antiviral Res; 2019 Jun; 166():56-65. PubMed ID: 30926288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
